Savior LLC’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8
| Closed | -$462 | – | 174 |
|
2022
Q4 | $462 | Sell |
8
-1
| -11% | -$58 | ﹤0.01% | 162 |
|
2022
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 192 |
|
2022
Q2 | $0 | Buy |
9
+2
| +29% | – | ﹤0.01% | 165 |
|
2022
Q1 | $0 | Buy |
7
+1
| +17% | – | ﹤0.01% | 163 |
|
2021
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 179 |
|
2021
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 166 |
|
2021
Q2 | $1K | Sell |
6
-1
| -14% | -$167 | ﹤0.01% | 774 |
|
2021
Q1 | $1K | Sell |
7
-2
| -22% | -$286 | ﹤0.01% | 802 |
|
2020
Q4 | $1K | Sell |
9
-2
| -18% | -$222 | ﹤0.01% | 769 |
|
2020
Q3 | $1K | Buy |
11
+1
| +10% | +$91 | ﹤0.01% | 735 |
|
2020
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 700 |
|